VEGF receptor-2 (Flk-1) overexpression in mice counteracts focal epileptic seizures.

by Litsa Nikitidou, Irene Kanter-Schlifke, Joke Dhondt, Peter Carmeliet, Diether Lambrechts, Mérab Kokaia
Published 2012-01-01

RIVA – a phase IIa study of rituximab and varlilumab in relapsed or refractory B-cell malignancies: study protocol for a randomized controlled trial

by Sean H. Lim, Kim M. Linton, Graham P. Collins, Joke Dhondt, Joshua Caddy, Liz Rossiter, Karan Vadher, Keira Fines, Laura E. Rogers, Diana Fernando, Louise Stanton, Andrew J. Davies, Peter W. M. Johnson, Gareth Griffiths
Published 2018-11-01